BFA
AXDX

BlackRock Fund Advisors’s Accelerate Diagnostics AXDX Stock Holding History

BlackRock Fund Advisors’s Portfolio AXDX Stock Details AXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$14.2M Buy
68,445
+9,370
+16% +$2.22M ﹤0.01% 2372
2016
Q3 		$16.1M Buy
59,075
+4,208
+8% +$931K ﹤0.01% 2177
2016
Q2 		$7.89M Sell
54,867
-3,686
-6% -$494K ﹤0.01% 2541
2016
Q1 		$8.41M Buy
58,553
+4,969
+9% +$701K ﹤0.01% 2458
2015
Q4 		$11.5M Buy
53,584
+2,262
+4% +$413K ﹤0.01% 2359
2015
Q3 		$8.3M Sell
51,322
-493
-1% -$107K ﹤0.01% 2486
2015
Q2 		$13.4M Sell
51,815
-6,479
-11% -$1.55M ﹤0.01% 2350
2015
Q1 		$13.1M Buy
58,294
+1,135
+2% +$237K ﹤0.01% 2303
2014
Q4 		$11M Buy
57,159
+8,326
+17% +$1.78M ﹤0.01% 2410
2014
Q3 		$10.5M Sell
48,833
-1,224
-2% -$238K ﹤0.01% 2318
2014
Q2 		$13M Buy
50,057
+18,841
+60% +$4.11M ﹤0.01% 2255
2014
Q1 		$6.81M Buy
31,216
+1,051
+3% +$156K ﹤0.01% 2628
2013
Q4 		$3.68M Buy
30,165
+260
+0.9% +$34.8K ﹤0.01% 2988
2013
Q3 		$4.01M Buy
29,905
+4,006
+15% +$358K ﹤0.01% 2945
2013
Q2 		$2.1M Buy
+25,899
New +$1.92M ﹤0.01% 3088

Other funds holding AXDX

OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
JMPWA
JP Morgan Private Wealth Advisors San Francisco, California $35B AUM 24.26% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return

BlackRock Fund Advisors's AXDX Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Accelerate Diagnostics (AXDX) stake by 16% in Q4 2016, buying an estimated $2.22M and bringing the position to 68,445 shares worth $14.2M. The position accounts for ﹤0.01% of the portfolio, ranked #2372.

BlackRock Fund Advisors first reported a position in AXDX in Q2 2013 and has held it in 15 quarters since. The position peaked at $16.1M in Q3 2016. 109 funds tracked by Wall St. Rank hold AXDX as of Q4 2016.

  • BlackRock Fund Advisors held 68,445 shares of Accelerate Diagnostics worth $14.2M as of Q4 2016.
  • BlackRock Fund Advisors bought 9,370 Accelerate Diagnostics shares in Q4 2016, an estimated $2.22M.
  • Accelerate Diagnostics made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #2372 holding.
  • BlackRock Fund Advisors first reported a position in Accelerate Diagnostics in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Fund Advisors's Accelerate Diagnostics position peaked at $16.1M in Q3 2016.
  • 109 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.